Does ADHD Medication Cause Hair Loss?

ADHD medications have been linked to hair loss, but the connection appears to be rare and shows up almost entirely in individual case reports rather than in large-scale studies. The best-documented cases involve methylphenidate, where patients experienced diffuse thinning that reversed after the drug was stopped. The evidence is thin enough that hair loss does not appear as a prominent warning on most ADHD medication labels, yet the reports are consistent enough that the possibility is worth taking seriously if you notice unusual shedding after starting or changing a prescription.

What the Case Reports Show

The clearest published evidence involves methylphenidate, the active ingredient in drugs like Ritalin and Concerta. A case series documented three patients who developed hair loss while taking methylphenidate for ADHD; in each case, the hair loss reversed after the medication was discontinued.¹ A separate case study described a boy who developed diffuse thinning across his entire scalp roughly two weeks after starting methylphenidate. His doctors ran a comprehensive workup covering thyroid function, iron levels, zinc, copper, vitamin B12, folic acid, and several infections. Everything came back normal, which pointed to the drug as the cause. After methylphenidate was stopped, his hair recovered within about a month.²

Non-stimulant ADHD medications are not entirely off the hook either. One published report described an eight-year-old girl who lost eyebrow hair on both sides after starting atomoxetine, a non-stimulant sold under the brand name Strattera. The authors noted it was the first documented case of eyebrow-specific hair loss associated with atomoxetine.³ In the methylphenidate case series mentioned above, one patient was switched from methylphenidate to atomoxetine after developing hair loss, and regrowth followed over roughly three months.¹

The overall picture from published literature is that drug-induced hair loss from ADHD medications has only been reported in a handful of patients. This places it firmly in the “uncommon adverse effect” category, alongside a short list of other psychotropic drugs known to occasionally cause hair loss, including lithium, valproic acid, and certain antidepressants like venlafaxine, fluoxetine, and sertraline.²

Why Stimulants Might Affect Hair Growth

The exact mechanism behind stimulant-related hair loss has not been nailed down, but laboratory research on dopamine and hair follicles offers a plausible explanation. Stimulant medications like methylphenidate and amphetamine work by increasing dopamine levels in the brain. Research on human scalp hair follicles grown in laboratory conditions found that dopamine directly promotes the transition of hair follicles from their active growth phase into the regression phase, where growth slows and eventually stops. The researchers suggested this could explain why some patients treated with dopamine-boosting drugs experience a type of shedding called telogen effluvium, where a higher-than-normal proportion of hairs shift into a resting state and fall out.⁴

There is also a second, more indirect route that involves a hormone called prolactin. Dopamine normally keeps prolactin in check, but the relationship between stimulant medication and prolactin is complicated and can vary between individuals. Research has shown that prolactin itself acts directly on hair follicles, pushing them into the regression phase by reducing the growth of hair bulb cells and increasing cell death in the follicle. High doses of prolactin applied to human scalp follicles in laboratory conditions slowed hair shaft growth and triggered premature regression.⁵ The researchers noted that this mechanism could explain the poorly understood hair loss seen in patients with abnormally high prolactin levels.

Both of these pathways are biologically plausible, but it is worth emphasizing that they come from laboratory studies on isolated hair follicles, not from clinical trials in people taking ADHD medication. That gap matters. The concentration of dopamine reaching your scalp when you take a therapeutic dose of Ritalin is very different from what researchers apply directly to a hair follicle in a dish. This may be part of the reason the effect is rare rather than universal.

When the Problem Is Hair Pulling, Not Hair Loss

Not every case of hair loss during stimulant treatment is the drug directly poisoning the follicle. Stimulant medications can sometimes trigger trichotillomania, a condition where a person compulsively pulls out their own hair. A published case report described a 12-year-old girl who started pulling her hair soon after beginning Adderall for ADHD. She reported that the pulling relieved anxiety the medication seemed to cause. Critically, the behavior had never appeared before Adderall, and it stopped completely after the medication was discontinued with no relapse over a year of follow-up.⁶

A systematic review that gathered case reports and case series of skin and hair-related side effects from prescription stimulants found that stimulant-induced trichotillomania typically affected pediatric male patients being treated for ADHD. In the cases reviewed, symptoms resolved after the medication was stopped.⁷

This distinction between direct drug-induced shedding and drug-induced hair pulling is important for figuring out what is actually happening. If you or your child is thinning on stimulants, it is worth observing whether there is a pulling or tugging habit that was not there before. The treatments are quite different: direct drug-related shedding usually resolves with a medication change, while trichotillomania may need behavioral therapy even if the triggering medication is stopped.

Alopecia Areata and Stimulant Use

Alopecia areata is a different kind of hair loss where the immune system attacks hair follicles, creating round bald patches rather than the diffuse thinning seen in telogen effluvium. A case-control study looked at whether ADHD stimulant medication was associated with alopecia areata by comparing patients with the condition to matched controls over a 10-year period. The study included 124 cases and 372 controls. Among the findings, males were more likely than females to use stimulant medication for ADHD.⁸

The relationship between stimulants and autoimmune hair loss is more speculative than the telogen effluvium link. Stimulants can alter immune function in subtle ways, and stress is a recognized trigger for alopecia areata in people who are already predisposed to it. If you develop patchy bald spots rather than general thinning, the underlying process may be immunological, and a dermatologist should evaluate it regardless of what medications you take.

Confounders That Make the Picture Messier

One of the trickier aspects of figuring out whether your ADHD medication is behind hair loss is that several features of ADHD itself, and of the lifestyle changes stimulants can cause, independently raise the risk of shedding.

Appetite suppression is one of the most common side effects of stimulant medications. People who eat less may get insufficient iron, zinc, or protein, all of which matter for hair growth. The relationship between iron deficiency and hair loss has been studied extensively, with research suggesting that low iron stores may contribute to several types of hair loss, including telogen effluvium and diffuse shedding.⁹ If you have been eating less since starting a stimulant, nutritional deficiency may be the actual culprit rather than the drug’s direct effect on follicles.

Stress is another major variable. Unmanaged ADHD can be profoundly stressful, but so can the transition period of starting medication, adjusting doses, or dealing with side effects. Psychological stress is one of the best-documented triggers for telogen effluvium in the general population. Sorting out whether the drug itself, the stress of ADHD, the stress of treatment changes, or poor nutrition is behind shedding is genuinely difficult. The thorough blood workup described in the methylphenidate case study, covering iron, zinc, copper, thyroid function, and B12, is exactly the kind of detective work needed to narrow things down.²

What to Do If You Notice Thinning

The encouraging pattern across the published case reports is that hair loss associated with ADHD medication appears to be reversible. In the methylphenidate cases, regrowth was noted within three to four weeks of discontinuation and full recovery took roughly three months.¹ That timeline is consistent with telogen effluvium in general: once the trigger is removed, follicles cycle back into active growth over a few months.

If you are experiencing hair thinning on ADHD medication, a few practical steps can help clarify the situation:

Track the timeline: Note when shedding began relative to starting or changing your medication. A gap of a few weeks to a couple of months is typical for drug-related telogen effluvium because follicles take time to shift phases.
Get blood work done: Ask for tests covering iron and ferritin, zinc, thyroid hormones, and vitamin B12 at a minimum. Ruling out nutritional and thyroid causes is important because those need their own treatment regardless of what you do with your ADHD medication.
Watch for pulling behavior: Especially in children, hair loss that concentrates in areas where hands naturally rest or where pulling is physically easy may indicate trichotillomania rather than direct follicle shedding.
Talk to your prescriber before stopping anything: In the published cases, patients were either switched to a different ADHD medication or taken off the suspected drug under medical supervision. Abruptly stopping a medication without your doctor’s input can create its own problems.

Switching between medication classes is one of the documented approaches. In one of the methylphenidate cases, switching to atomoxetine led to hair regrowth, suggesting the shedding was specific to that stimulant rather than to all ADHD drugs.¹ However, the isolated atomoxetine eyebrow case shows that non-stimulants are not completely free of this side effect either.³ The choice of alternative depends on your individual response and your prescriber’s clinical judgment.

Why This Side Effect Is Probably Underreported

The fact that published evidence consists almost entirely of case reports and small case series does not necessarily mean the problem is as vanishingly rare as the literature suggests. Drug-induced hair loss is easy to miss or dismiss. Patients may not connect gradual thinning to a medication they started weeks earlier. Prescribers focused on managing ADHD symptoms may not ask about hair. And when hair loss does come up in a clinical visit, the first assumption is often stress or genetics, especially in adults.

There is also a reporting bias in the literature. Case reports get written when something is unusual enough to catch a clinician’s attention and when that clinician decides it is worth documenting. Mild thinning that reverses after a dose adjustment, or shedding that a patient simply tolerates because the medication otherwise helps them function, rarely makes it into a journal. The true incidence of hair thinning among people taking ADHD stimulants could be higher than the handful of published cases implies, though there is no way to estimate how much higher without systematic data collection.

The absence of large epidemiological studies on this specific side effect is a real limitation. Most of the large clinical trials that led to FDA approval of ADHD medications tracked common adverse events like appetite loss, insomnia, and elevated heart rate. Hair loss was not a primary outcome in any of those trials, so mild or moderate shedding could easily have been missed in the noise. Until someone designs a study specifically looking at hair outcomes in stimulant users, the best evidence will remain what we have now: a consistent pattern in scattered case reports, plausible mechanisms from laboratory research, and the reassuring observation that the effect seems to go away once the medication does.

Stimulant-Related Skin and Hair Effects Beyond Shedding

Hair loss is not the only way stimulant medications can affect the skin and its appendages. The systematic review that identified stimulant-induced trichotillomania also documented tactile hallucinations and delusional infestation as psychocutaneous side effects of prescription stimulants.⁷ Tactile hallucinations involve feeling sensations on the skin that are not really there, like crawling or itching, which can lead to scratching or picking that damages the scalp and hair. These effects were more commonly associated with misuse or high doses of stimulants, but they appeared at therapeutic doses as well.

If you are on stimulant medication and notice not just thinning but also unusual skin sensations, excessive scratching, or picking at your scalp, those symptoms may be related and worth bringing up with your prescriber at the same time. The broader category of psychocutaneous effects is an underappreciated area that goes beyond what most patients expect from ADHD medication, and clinicians who treat both ADHD and dermatological complaints are in the best position to connect the dots.

1
PubMed Central. Alopecia Associated with Use of Methylphenidate: A Case Series
2
PubMed Central. Hair loss due to methylphenidate use: A case study
3
PubMed Central. Atomoxetine-Associated Eyebrow Alopecia in a Girl With Attention-Deficit/Hyperactivity Disorder
4
PubMed. Dopamine is a novel, direct inducer of catagen in human scalp hair follicles in vitro
5
PubMed Central. Human Scalp Hair Follicles Are Both a Target and a Source of Prolactin, which Serves as an Autocrine and/or Paracrine Promoter of Apoptosis-Driven Hair Follicle Regression
6
PubMed Central. Adderall-induced Trichotillomania: A Case Report
7
PubMed. Adverse psychocutaneous effects of prescription stimulant use and abuse: A systematic review
8
PubMed Central. Association of Alopecia Areata With Attention-Deficit/Hyperactivity Disorder Stimulant Medication: A Case-Control Study
9
ScienceDirect. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss